As your browser does not support javascript you won't be able to use all the features of the website. We strongly recommend you to enable the javascript in your old browser's settings or download a new one.

All posts from Actionable news

Actionable news in ACHN: Achillion Pharmaceuticals, Inc., 19 may 2016

Janssen readies mid-stage study of short duration HCV combo regimen for genotypes 1-6

Janssen Pharmaceuticals' (NYSE:JNJ) Janssen Research & Development, LLC initiates a Phase 2b clinical trial assessing the safety, pharmacokinetics and efficacy of different regimens of AL-335, odalasvir and simeprevir in treatment-naive and treatment-experienced patients with chronic hepatitis C virus (HCV) genotype 1-6...

Comments 0

My posts

Q ...
15 june 2015
- v 120
- K 0
- Z 0
Happy Independence Day, America!
5 july 2015
- v 109
- K 0
- Z 0
“I hate America… I hate Americans…” she said.
13 july 2015
- v 147
- K 0
- Z 0

View all posts